Invivogen
Menu

IFN-γ Reporter HEK 293 Cells

HEK-Dual™ IFN-γ cells Unit size Cat. code Docs Qty Price
Human IFN-γ SEAP/Luciferase Reporter Cells
3-7 x 10e6 cells
hkd-ifng
+-
$1,260.00

You may also need : Puromycin | View more associated products

Human Interferon-γ Reporter Cells

HEK-Dual™ IFN-γ Cells signaling pathway
HEK-Dual™ IFN-γ Cells signaling pathway

HEK-Dual™ IFN-γ cells allow the detection of bioactive human interferon-γ (IFN-γ) by monitoring the activation of the JAK/STAT-1 pathway by assessing the activity of two different reporters, SEAP (secreted embryonic alkaline phosphatase) or Lucia luciferase, a secreted luciferase.

IFN-γ, a Type II IFN, is a pleiotropic cytokine with anti-viral, anti-tumor, and immunomodulatory functions [1]. IFN-γ binds a heterodimeric receptor consisting of two subunits, IFNGR1 and IFNGR2, associated with JAK1 and JAK2, respectively. Upon binding to this receptor, IFN-γ triggers JAK/STAT signaling. Activated STAT1 molecules form homodimers and are translocated to the nucleus where they bind interferon-gamma-activated sites (GAS) in the promoter of IFN-γ inducible genes.

 More details

 

Cell line description:

HEK-Dual™ IFN-γ cells were generated by stable transfection of the human embryonic kidney HEK293 cell line with the human STAT1 gene to obtain a fully active STAT1 pathway.  The other genes of the pathway are naturally expressed in sufficient amounts.

These cells were further transfected with two reporter genes, SEAP and Lucia luciferase, under the control of an IFN-γ inducible promoter. As a result, HEK-Dual™ IFN-γ cells allow studying the activation of JAK/STAT-1 pathway, by monitoring the activity of two different reporters, SEAP or Lucia luciferase.

Both reporter proteins are readily measurable in the cell culture supernatant when using QUANTI-Blue™ Solution, a SEAP detection reagent, and QUANTI-Luc™, a luciferase detection reagent.


Features of HEK-Dual™ IFN-γ cells:

  • Fully functional IFN-γ signaling pathway
  • Readily assessable SEAP and Lucia luciferase reporter activity
  • Functionally tested and guaranteed mycoplasma-free


Applications of HEK-Dual™ IFN-γ cells:

  • Detection of human IFN-γ
  • Screening of anti-hIFN-γ antibodies

 

Reference:

1. Ivashkiv L.B., 2018. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 18(9):545-558.

Figures

 hek dual ifng
 hek dual ifng

HEK-Blue™ IFN-γ cells and HEK-Dual™ IFN-γ cells were incubated with increasing concentrations of recombinant human IFN-γ. After 24h incubation the levels of STAT1-induced SEAP and STAT1-induced Lucia luciferase were determined using QUANTI-Blue™ and QUANTI-Luc™, respectively. SEAP activity was assessed by measuring the OD at 655 while Lucia luciferase activity was determined by measuring Relative Light Units (RLU).

Back to the top

Specifications

Antibiotic resistance: blasticidin, Zeocin™, puromycin

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

  • Detection range for human IFN-γ using QUANTI-Luc™: 1 - 10e3IU/ml
  • Detection range for human IFN-γ using QUANTI-Blue™: 5 - 100IU/ml

 

These products are covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

  • 1 vial of HEK-Dual™ IFN-γ Cells (3-7 x 10e6 cells)
  • 1 ml of Blasticidin (10 mg/ml).
  • 1 ml of Puromycin (10 mg/ml).
  • 1 ml of Zeocin™ (100 mg/ml).
  • 1 ml of Normocin™ (50 mg/ml).
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
  • 1 pouch of QUANTI-Luc™ (Lucia luciferase detection medium)

Shipped on dry ice (Europe, USA & Canada)

Back to the top

Details

Interferon-gamma (IFN-γ), a Type II interferon, is secreted from CD4+ T-helper 1 (Th1) cells and activated natural killer (NK) cells. It plays a role in activating lymphocytes to enhance anti-microbial and anti-tumor effects [1-3]. In addition, IFN-γ plays a role in regulating the proliferation, differentiation, and response of lymphocyte subsets. 

IFN-γ exerts its action by first binding to a heterodimeric receptor consisting of two chains, IFNGR1 and IFNGR2, causing its dimerization and the activation of specific Janus family kinases (JAK1 and JAK2) [4, 5]. Two STAT1 molecules then associate with this ligand-activated receptor complex and are activated by phosphorylation. Activated STAT1 forms homodimers and are translocated to the nucleus where they bind interferon-gamma-activated sites (GAS) in the promoter of IFN-γ inducible genes.

 

1. Ivashkiv L.B., 2018. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 18(9):545-558.
2. Shtrichman R. & Samuel CE., 2001. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol. 4(3):251-9.
3. Sato A. et al., 2006. Antitumor activity of IFN-lambda in murine tumor models. J Immunol. 176(12):7686-94.
4. Platanias L.C., 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 5(5):375-86.
5. Schroder K. et al., 2004. Interferon-gamma: an overview of signals, mechanisms, and functions. J Leukoc Biol. 75(2):163-89.

Back to the top

FAQ

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty